Entheon Biomedical Corp. Acquires Lobo Genetics Inc.
Ryan Allway July 30th, 2021 Psychedelics Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols Vancouver, British Columbia–(Newsfile Corp. – July 30, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“) is pleased to announce that the Company completed its acquisition... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )